BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27387531)

  • 1. AβPP processing results in greater toxicity per amount of Aβ1-42 than individually expressed and secreted Aβ1-42 in Drosophila melanogaster.
    Bergkvist L; Sandin L; Kågedal K; Brorsson AC
    Biol Open; 2016 Aug; 5(8):1030-9. PubMed ID: 27387531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.
    Bergkvist L; Du Z; Elovsson G; Appelqvist H; Itzhaki LS; Kumita JR; Kågedal K; Brorsson AC
    FEBS Open Bio; 2020 Mar; 10(3):338-350. PubMed ID: 31823504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.
    Sandin L; Bergkvist L; Nath S; Kielkopf C; Janefjord C; Helmfors L; Zetterberg H; Blennow K; Li H; Nilsberth C; Garner B; Brorsson AC; Kågedal K
    FEBS J; 2016 Oct; 283(19):3508-3522. PubMed ID: 27562772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model.
    Borghys H; Jacobs T; Van Broeck B; Dillen L; Dhuyvetter D; Gijsen H; Mercken M
    J Alzheimers Dis; 2014; 38(1):39-48. PubMed ID: 23948925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
    Hampel H; Shen Y
    Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.
    Agostinho P; Pliássova A; Oliveira CR; Cunha RA
    J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
    Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
    J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease.
    Portelius E; Olsson M; Brinkmalm G; Rüetschi U; Mattsson N; Andreasson U; Gobom J; Brinkmalm A; Hölttä M; Blennow K; Zetterberg H
    J Alzheimers Dis; 2013; 33(1):85-93. PubMed ID: 22886024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BACE1-PSEN-AβPP regulatory axis has an ancient role in response to low oxygen/oxidative stress.
    Moussavi Nik SH; Wilson L; Newman M; Croft K; Mori TA; Musgrave I; Lardelli M
    J Alzheimers Dis; 2012; 28(3):515-30. PubMed ID: 22045484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and post-transcriptional regulation of β-secretase.
    Tamagno E; Guglielmotto M; Monteleone D; Vercelli A; Tabaton M
    IUBMB Life; 2012 Dec; 64(12):943-50. PubMed ID: 23180460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage.
    Portelius E; Dean RA; Andreasson U; Mattsson N; Westerlund A; Olsson M; Demattos RB; Racke MM; Zetterberg H; May PC; Blennow K
    Alzheimers Res Ther; 2014; 6(5-8):75. PubMed ID: 25404952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
    Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
    J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific tandem single chain antibody simultaneously inhibits β-secretase and promotes α-secretase processing of AβPP.
    Boddapati S; Levites Y; Suryadi V; Kasturirangan S; Sierks MR
    J Alzheimers Dis; 2012; 28(4):961-9. PubMed ID: 22156046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are γ-secretase and its associated Alzheimer's disease γ problems?
    Rodríguez-Manotas M; Amorín-Díaz M; Cabezas-Herrera J; Acedo-Martínez A; Llorca-Escuín I
    Med Hypotheses; 2012 Feb; 78(2):299-304. PubMed ID: 22133557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
    Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
    FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.